BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut. 1995;36:718-723. [PMID: 7541008 DOI: 10.1136/gut.36.5.718] [Cited by in Crossref: 253] [Cited by in F6Publishing: 245] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Petersson J, Schreiber O, Steege A, Patzak A, Hellsten A, Phillipson M, Holm L. eNOS involved in colitis-induced mucosal blood flow increase. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007;293:G1281-7. [DOI: 10.1152/ajpgi.00357.2007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
2 Vodovotz Y. Control of Nitric Oxide Production by Transforming Growth Factor-β1: Mechanistic Insights and Potential Relevance to Human Disease. Nitric Oxide 1997;1:3-17. [DOI: 10.1006/niox.1996.0105] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 3.2] [Reference Citation Analysis]
3 Mahgoub A, El-medany A, Mustafa A, Arafah M, Moursi M. Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. Toxicology and Applied Pharmacology 2005;205:43-52. [DOI: 10.1016/j.taap.2004.09.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
4 Piechota-Polanczyk A, Fichna J. Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn Schmiedebergs Arch Pharmacol. 2014;387:605-620. [PMID: 24798211 DOI: 10.1007/s00210-014-0985-1] [Cited by in Crossref: 165] [Cited by in F6Publishing: 146] [Article Influence: 23.6] [Reference Citation Analysis]
5 Vermeiren J, Hindryckx P, Van Nieuwenhuyse G, Laukens D, De Vos M, Boon N, Van de Wiele T. Intrarectal nitric oxide administration prevents cellular infiltration but not colonic injury during dextran sodium sulfate colitis. Dig Dis Sci 2012;57:1832-7. [PMID: 22419056 DOI: 10.1007/s10620-012-2105-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 Toumi R, Soufli I, Rafa H, Belkhelfa M, Biad A, Touil-Boukoffa C. Probiotic bacteria lactobacillus and bifidobacterium attenuate inflammation in dextran sulfate sodium-induced experimental colitis in mice. Int J Immunopathol Pharmacol. 2014;27:615-627. [PMID: 25572742 DOI: 10.1177/039463201402700418] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
7 Choi EY, Jin JY, Lee JY, Choi JI, Choi IS, Kim SJ. Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity. J Pineal Res 2011;50:197-206. [PMID: 21158907 DOI: 10.1111/j.1600-079X.2010.00829.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
8 Bourgonje AR, von Martels JZH, Bulthuis MLC, van Londen M, Faber KN, Dijkstra G, van Goor H. Crohn's Disease in Clinical Remission Is Marked by Systemic Oxidative Stress. Front Physiol 2019;10:499. [PMID: 31080419 DOI: 10.3389/fphys.2019.00499] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
9 Rafa H, Amri M, Saoula H, Belkhelfa M, Medjeber O, Boutaleb A, Aftis S, Nakmouche M, Touil-Boukoffa C. Involvement of interferon-γ in bowel disease pathogenesis by nitric oxide pathway: a study in Algerian patients. J Interferon Cytokine Res. 2010;30:691-697. [PMID: 20626296 DOI: 10.1089/jir.2010.0012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
10 Korkmaz AG, Popov T, Peisl L, Codrea MC, Nahnsen S, Steimle A, Velic A, Macek B, von Bergen M, Bernhardt J, Frick JS. Proteome and phosphoproteome analysis of commensally induced dendritic cell maturation states. J Proteomics 2018;180:11-24. [PMID: 29155090 DOI: 10.1016/j.jprot.2017.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Oliver J, Gómez-Garcia M, Vilchez JR, López-Nevot MA, Piñero A, Correro F, Nieto A, Martín J. Inducible and endothelial nitric oxide synthase genes polymorphism in inflammatory bowel disease. Tissue Antigens 2006;67:326-30. [PMID: 16634870 DOI: 10.1111/j.1399-0039.2006.00578.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Chazotte-Aubert L, Pluquet O, Hainaut P, Ohshima H. Nitric oxide prevents gamma-radiation-induced cell cycle arrest by impairing p53 function in MCF-7 cells. Biochem Biophys Res Commun 2001;281:766-71. [PMID: 11237724 DOI: 10.1006/bbrc.2001.4423] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
13 Shusterman T, Sela S, Cohen H, Kristal B, Sbeit W, Reshef R. Effect of the antioxidant Mesna (2-mercaptoethane sulfonate) on experimental colitis. Dig Dis Sci. 2003;48:1177-1185. [PMID: 12822882 DOI: 10.1023/A:1023741518385] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
14 Mühl H, Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 2003;3:1247-55. [PMID: 12890422 DOI: 10.1016/S1567-5769(03)00131-0] [Cited by in Crossref: 162] [Cited by in F6Publishing: 80] [Article Influence: 9.5] [Reference Citation Analysis]
15 Kelloff GJ. Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res. 2000;78:199-334. [PMID: 10547671 DOI: 10.1016/s0065-230x(08)61026-x] [Cited by in Crossref: 169] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
16 Obermeier F, Kojouharoff G, Hans W, Schölmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol. 1999;116:238-245. [PMID: 10337013 DOI: 10.1046/j.1365-2249.1999.00878.x] [Cited by in Crossref: 211] [Cited by in F6Publishing: 204] [Article Influence: 9.6] [Reference Citation Analysis]
17 Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, Jansen PL, van Goor H. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol. 1998;186:416-421. [PMID: 10209492 DOI: 10.1002/(SICI)1096-9896(199812)186:4%3C416::AID-PATH201%3E3.0.CO;2-U] [Reference Citation Analysis]
18 Serna H, Porras M, Vergara P. Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat. J Pharmacol Exp Ther. 2006;319:1104-1111. [PMID: 16988056 DOI: 10.1124/jpet.106.104620] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
19 Hosoi T, Goto H, Arisawa T, Niwa Y, Okada N, Ohmiya N, Hayakawa T. Role of nitric oxide synthase inhibitor in experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats. Clin Exp Pharmacol Physiol 2001;28:9-12. [PMID: 11153546 DOI: 10.1046/j.1440-1681.2001.03388.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
20 Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA. The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 2005;26:1513-9. [DOI: 10.1093/carcin/bgi106] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
21 Janakiram NB, Rao CV. The role of inflammation in colon cancer. Adv Exp Med Biol. 2014;816:25-52. [PMID: 24818718 DOI: 10.1007/978-3-0348-0837-8_2] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 13.7] [Reference Citation Analysis]
22 Izzo AA, Mascolo N, Capasso F. Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci. 1998;43:1605-1620. [PMID: 9724140 DOI: 10.1023/a:1018887525293] [Cited by in Crossref: 103] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
23 Conner EM, Brand SJ, Davis JM, Kang DY, Grisham MB. Role of Reactive Metabolites of Oxygen and Nitrogen in Inflammatory Bowel Disease: Toxins, Mediators, and Modulators of Gene Expression: . Inflammatory Bowel Diseases 1996;2:133-47. [DOI: 10.1097/00054725-199606000-00011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
24 Mühl H, Chang JH, Huwiler A, Bosmann M, Paulukat J, Ninic R, Nold M, Hellmuth M, Pfeilschifter J. Nitric oxide augments release of chemokines from monocytic U937 cells: modulation by anti-inflammatory pathways. Free Radic Biol Med 2000;29:969-80. [PMID: 11084285 DOI: 10.1016/s0891-5849(00)00389-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Ellis G, Adatia I, Yazdanpanah M, Makela SK. Nitrite and nitrate analyses: a clinical biochemistry perspective. Clin Biochem 1998;31:195-220. [PMID: 9646943 DOI: 10.1016/s0009-9120(98)00015-0] [Cited by in Crossref: 193] [Cited by in F6Publishing: 22] [Article Influence: 8.4] [Reference Citation Analysis]
26 Depoortere I, Thijs T, Peeters TL. Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis. Br J Pharmacol. 2002;135:2011-2019. [PMID: 11959805 DOI: 10.1038/sj.bjp.0704648] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
27 Kamalian A, Sohrabi Asl M, Dolatshahi M, Afshari K, Shamshiri S, Momeni Roudsari N, Momtaz S, Rahimi R, Abdollahi M, Abdolghaffari AH. Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways. World J Gastroenterol 2020;26:3365-400. [PMID: 32655263 DOI: 10.3748/wjg.v26.i24.3365] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
28 Linehan JD, Kolios G, Valatas V, Robertson DA, Westwick J. Effect of corticosteroids on nitric oxide production in inflammatory bowel disease: are leukocytes the site of action? Am J Physiol Gastrointest Liver Physiol. 2005;288:G261-G267. [PMID: 15374815 DOI: 10.1152/ajpgi.00336.2004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
29 Kathiria AS, Butcher LD, Feagins LA, Souza RF, Boland CR, Theiss AL. Prohibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells. PLoS One. 2012;7:e31231. [PMID: 22363587 DOI: 10.1371/journal.pone.0031231] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
30 Seril DN, Liao J, Ho KK, Yang CS, Yang G. Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis 2002;23:993-1001. [DOI: 10.1093/carcin/23.6.993] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
31 McKay R, Ghodasra M, Schardt J, Quan D, Pottash AE, Shang W, Jay SM, Payne GF, Chang MW, March JC, Bentley WE. A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease. Bioeng Transl Med 2018;3:209-21. [PMID: 30377661 DOI: 10.1002/btm2.10113] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
32 Banan A, Fields JZ, Zhang Y, Keshavarzian A. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. American Journal of Physiology-Gastrointestinal and Liver Physiology 2001;280:G1234-46. [DOI: 10.1152/ajpgi.2001.280.6.g1234] [Cited by in Crossref: 81] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
33 Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000;30:78-84. [PMID: 10630444 DOI: 10.1097/00005176-200001000-00022] [Cited by in Crossref: 119] [Cited by in F6Publishing: 85] [Article Influence: 5.7] [Reference Citation Analysis]
34 Singh K, Gobert AP, Coburn LA, Barry DP, Allaman M, Asim M, Luis PB, Schneider C, Milne GL, Boone HH, Shilts MH, Washington MK, Das SR, Piazuelo MB, Wilson KT. Dietary Arginine Regulates Severity of Experimental Colitis and Affects the Colonic Microbiome. Front Cell Infect Microbiol 2019;9:66. [PMID: 30972302 DOI: 10.3389/fcimb.2019.00066] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
35 Tabernero A, Reimund J, Chasserot S, Muller CD, Andriantsitohaina R. Cyclooxygenase-2 Expression and Role of Vasoconstrictor Prostanoids in Small Mesenteric Arteries From Patients With Crohn’s Disease. Circulation 2003;107:1407-10. [DOI: 10.1161/01.cir.0000055321.13957.17] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
36 Reinshagen M, Egger B, Procaccino F, Eysselein VE. Neuropeptides in Inflammatory Bowel Disease: An Update: . Inflammatory Bowel Diseases 1997;3:303-13. [DOI: 10.1097/00054725-199712000-00008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
37 Palatka K, Serfozo Z, Veréb Z, Hargitay Z, Lontay B, Erdodi F, Bánfalvi G, Nemes Z, Udvardy M, Altorjay I. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Scand J Gastroenterol. 2005;40:670-680. [PMID: 16036527 DOI: 10.1080/00365520510015539] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
38 Bengmark S. Bioecological control of inflammatory bowel disease. Clin Nutr 2007;26:169-81. [PMID: 17113199 DOI: 10.1016/j.clnu.2006.10.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
39 Conner EM, Brand SJ, Davis JM, Kang DY, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: Toxins, mediators, and modulators of gene expression. Inflamm Bowel Dis 1996;2:133-47. [DOI: 10.1002/ibd.3780020211] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
40 Nishikawa M, Takeda K, Sato EF, Kuroki T, Inoue M. Nitric oxide regulates energy metabolism and Bcl-2 expression in intestinal epithelial cells. Am J Physiol 1998;274:G797-801. [PMID: 9612258 DOI: 10.1152/ajpgi.1998.274.5.G797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
41 Lu P, Zhang C, Fu L, Wei Y, Huang Y, Wang X, Lv C, Chen L. Near-Infrared Fluorescent Probe for Imaging and Evaluating the Role of Vanin-1 in Chemotherapy. Anal Chem 2021;93:10378-87. [PMID: 34275284 DOI: 10.1021/acs.analchem.1c02386] [Reference Citation Analysis]
42 Cavicchi M, Gibbs L, Whittle BJ. Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors. Gut. 2000;47:771-778. [PMID: 11076874 DOI: 10.1136/gut.47.6.771] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
43 Rachmilewitz D, Karmeli F, Shteingart S, Lee J, Takabayashi K, Raz E. Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis. Inflamm Bowel Dis. 2006;12:339-345. [PMID: 16670522 DOI: 10.1097/01.MIB.0000217335.30689.77] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
44 Menchén L, Colón AL, Madrigal JL, Beltrán L, Botella S, Lizasoain I, Leza JC, Moro MA, Menchén P, Cos E. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis. Am J Gastroenterol. 2004;99:1756-1764. [PMID: 15330915 DOI: 10.1111/j.1572-0241.2004.40065.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
45 Cavicchi M, Whittle BJ. Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation. Br J Pharmacol. 1999;128:705-715. [PMID: 10516652 DOI: 10.1038/sj.bjp.0702827] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
46 Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004;113:427-37. [PMID: 15554920 DOI: 10.1111/j.1365-2567.2004.01984.x] [Cited by in Crossref: 316] [Cited by in F6Publishing: 269] [Article Influence: 19.8] [Reference Citation Analysis]
47 Heydarpour P, Rahimian R, Fakhfouri G, Khoshkish S, Fakhraei N, Salehi-sadaghiani M, Wang H, Abbasi A, Dehpour AR, Ghia J. Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2016;64:131-41. [DOI: 10.1016/j.pnpbp.2015.08.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
48 Triantafyllidis I, Poutahidis T, Taitzoglou I, Kesisoglou I, Lazaridis C, Botsios D. Treatment with Mesna and n-3 polyunsaturated fatty acids ameliorates experimental ulcerative colitis in rats. Int J Exp Pathol 2015;96:433-43. [PMID: 26852691 DOI: 10.1111/iep.12163] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
49 Romero M, Vera B, Galisteo M, Toral M, Gálvez J, Perez-vizcaino F, Duarte J. Protective vascular effects of quercitrin in acute TNBS-colitis in rats: the role of nitric oxide. Food Funct 2017;8:2702-11. [DOI: 10.1039/c7fo00755h] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
50 Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res. 2012;2:6. [PMID: 22417628 DOI: 10.1186/2045-9912-2-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
51 Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, Jhappan C, Higashimoto Y, He P, Linke SP. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA. 2003;100:143-148. [PMID: 12518062 DOI: 10.1073/pnas.0237083100] [Cited by in Crossref: 257] [Cited by in F6Publishing: 216] [Article Influence: 13.5] [Reference Citation Analysis]
52 Coyle Y. Adjuvant and Neoadjuvant Therapy for Colorectal Cancer. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. Elsevier; 2019. pp. 2126-36. [DOI: 10.1016/b978-0-323-40232-3.00176-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Blachier F, Mariotti F, Huneau JF, Tomé D. Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 2007;33:547-62. [DOI: 10.1007/s00726-006-0477-9] [Cited by in Crossref: 239] [Cited by in F6Publishing: 198] [Article Influence: 15.9] [Reference Citation Analysis]
54 Rajora N, Boccoli G, Catania A, Lipton JM. alpha-MSH modulates experimental inflammatory bowel disease. Peptides. 1997;18:381-385. [PMID: 9145424 DOI: 10.1016/s0196-9781(96)00345-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
55 Chen K, Hirota S, Wasa M, Okada A. Expression of NOS II and its role in experimental small bowel ulceration in rats. Surgery. 1999;126:553-561. [PMID: 10486609 DOI: 10.1016/s0039-6060(99)70098-x] [Cited by in Crossref: 10] [Article Influence: 0.5] [Reference Citation Analysis]
56 Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014;20:9872-9881. [PMID: 25110418 DOI: 10.3748/wjg.v20.i29.9872] [Cited by in CrossRef: 189] [Cited by in F6Publishing: 157] [Article Influence: 31.5] [Reference Citation Analysis]
57 Pagoldh M, Hultgren E, Arnell P, Eriksson A. Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study. Scandinavian Journal of Gastroenterology 2013;48:1033-40. [DOI: 10.3109/00365521.2013.819443] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
58 Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:179-189. [PMID: 12792224 DOI: 10.1097/00054725-200305000-00006] [Cited by in Crossref: 191] [Cited by in F6Publishing: 179] [Article Influence: 10.6] [Reference Citation Analysis]
59 Seiler N, Raul F. Polyamines and the intestinal tract. Crit Rev Clin Lab Sci 2007;44:365-411. [PMID: 17558654 DOI: 10.1080/10408360701250016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
60 Kathiria AS, Butcher MA, Hansen JM, Theiss AL. Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis. Am J Physiol Gastrointest Liver Physiol 2013;304:G885-96. [PMID: 23494124 DOI: 10.1152/ajpgi.00327.2012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
61 Santhanam S, Rajamanickam S, Motamarry A, Ramakrishna BS, Amirtharaj JG, Ramachandran A, Pulimood A, Venkatraman A. Mitochondrial electron transport chain complex dysfunction in the colonic mucosa in ulcerative colitis. Inflamm Bowel Dis. 2012;18:2158-2168. [PMID: 22374887 DOI: 10.1002/ibd.22926] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
62 Koster-kamphuis L, van Straaten EA, Kors WA, De Schrijver JEAR, Bovee-oudenhoven IMY, van der Meer R, Forget P. Urinary NOx:Creatinine Ratios During Gluten Challenge in Children With Celiac Disease: . Journal of Pediatric Gastroenterology and Nutrition 2003;36:372-5. [DOI: 10.1097/00005176-200303000-00013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
63 Durmus AS, Tuzcu M, Ozdemir O, Orhan C, Sahin N, Ozercan IH, Komorowski JR, Ali S, Sahin K. Arginine Silicate Inositol Complex Accelerates Cutaneous Wound Healing. Biol Trace Elem Res 2017;177:122-31. [PMID: 27743199 DOI: 10.1007/s12011-016-0857-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Banan A, Zhang L, Fields JZ, Farhadi A, Talmage DA, Keshavarzian A. PKC-zeta prevents oxidant-induced iNOS upregulation and protects the microtubules and gut barrier integrity. Am J Physiol Gastrointest Liver Physiol. 2002;283:G909-G922. [PMID: 12223351 DOI: 10.1152/ajpgi.00143.2002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
65 Kankuri E, Asmawi MZ, Korpela R, Vapaatalo H, Moilanen E. Induction of iNOS in a rat model of acute colitis. Inflammation. 1999;23:141-152. [PMID: 10213270 DOI: 10.1023/a:1020241028723] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
66 McCafferty DM, Sihota E, Muscara M, Wallace JL, Sharkey KA, Kubes P. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 2000;279:G90-9. [PMID: 10898750 DOI: 10.1152/ajpgi.2000.279.1.G90] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
67 Wang E, Spitzer JJ, Chamulitrat W. Differential regulation of inducible nitric oxide synthase gene expression by ethanol in the human intestinal epithelial cell line DLD-1. Nitric Oxide 1999;3:244-53. [PMID: 10442856 DOI: 10.1006/niox.1999.0230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
68 Szabo C. Regulation of the Expression of the Inducible Isoform of Nitric Oxide Synthase by Glucocorticoidsa. Annals NY Acad Sci 1998;851:336-41. [DOI: 10.1111/j.1749-6632.1998.tb09007.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
69 Lamine F, Fioramonti J, Bueno L, Nepveu F, Cauquil E, Lobysheva I, Eutamène H, Théodorou V. Nitric oxide released by Lactobacillus farciminis improves TNBS-induced colitis in rats. Scand J Gastroenterol. 2004;39:37-45. [PMID: 14992560 DOI: 10.1080/00365520310007152] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
70 Vivien R. Colonic Fluid and Electrolyte Transport in Health and Disease. Veterinary Clinics of North America: Small Animal Practice 1999;29:577-88. [DOI: 10.1016/s0195-5616(99)50035-1] [Cited by in Crossref: 13] [Article Influence: 0.6] [Reference Citation Analysis]
71 Riazi K, Honar H, Homayoun H, Demehri S, Bahadori M, Dehpour AR. Intestinal inflammation alters the susceptibility to pentylenetetrazole-induced seizure in mice. J Gastroenterol Hepatol 2004;19:270-7. [PMID: 14748873 DOI: 10.1111/j.1440-1746.2003.03284.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
72 Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807-16. [PMID: 21530747 DOI: 10.1053/j.gastro.2011.01.057] [Cited by in Crossref: 628] [Cited by in F6Publishing: 557] [Article Influence: 62.8] [Reference Citation Analysis]
73 Hokari R, Kato S, Matsuzaki K, Kuroki M, Iwai A, Kawaguchi A, Nagao S, Miyahara T, Itoh K, Sekizuka E, Nagata H, Ishii H, Miura S. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med 2001;31:153-63. [PMID: 11440827 DOI: 10.1016/s0891-5849(01)00565-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
74 Toumi R, Abdelouhab K, Rafa H, Soufli I, Raissi-Kerboua D, Djeraba Z, Touil-Boukoffa C. Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis. Immunopharmacol Immunotoxicol. 2013;35:403-409. [PMID: 23638770 DOI: 10.3109/08923973.2013.790413] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
75 Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishii H. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut. 1998;42:180-187. [PMID: 9536941 DOI: 10.1136/gut.42.2.180] [Cited by in Crossref: 165] [Cited by in F6Publishing: 155] [Article Influence: 7.2] [Reference Citation Analysis]
76 Tomobuchi M, Oshitani N, Matsumoto T, Kitano A, Seki S, Arakawa T. In situ generation of nitric oxide by myenteric neurons but not by mononuclear cells of the human colon. Clin Exp Pharmacol Physiol. 2001;28:13-18. [PMID: 11153529 DOI: 10.1046/j.1440-1681.2001.03396.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
77 Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice. European Journal of Pharmacology 2001;412:91-9. [DOI: 10.1016/s0014-2999(00)00926-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
78 Nakanishi R, Shimizu T, Kumagai K, Takai A, Marusawa H. Genetic Pathogenesis of Inflammation-Associated Cancers in Digestive Organs. Pathogens 2021;10:453. [PMID: 33918902 DOI: 10.3390/pathogens10040453] [Reference Citation Analysis]
79 Li Q, Sarna SK. Nitric oxide modifies chromatin to suppress ICAM-1 expression during colonic inflammation. Am J Physiol Gastrointest Liver Physiol 2012;303:G103-10. [PMID: 22517771 DOI: 10.1152/ajpgi.00381.2011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
80 Dykhuizen RS, Masson J, McKnight G, Mowat AN, Smith CC, Smith LM, Benjamin N. Plasma nitrate concentration in infective gastroenteritis and inflammatory bowel disease. Gut 1996;39:393-5. [PMID: 8949643 DOI: 10.1136/gut.39.3.393] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 1.8] [Reference Citation Analysis]
81 Miura S, Tsuzuki Y, Hokari R, Ishii H. Modulation of intestinal immune system by dietary fat intake: Relevance to Crohn's disease. J Gastroenterol Hepatol 1998;13:1183-90. [DOI: 10.1111/j.1440-1746.1998.tb00602.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
82 Akobeng AK, Miller V, Thomas AG, Richmond K. Glutamine supplementation and intestinal permeability in Crohn's disease. JPEN J Parenter Enteral Nutr 2000;24:196. [PMID: 10850950 DOI: 10.1177/0148607100024003196] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
83 Bagyánszki M, Torfs P, Krecsmarik M, Fekete E, Adriaensen D, Van Nassauw L, Timmermans JP, Kroese AB. Chronic alcohol consumption induces an overproduction of NO by nNOS- and iNOS-expressing myenteric neurons in the murine small intestine. Neurogastroenterol Motil 2011;23:e237-48. [PMID: 21470341 DOI: 10.1111/j.1365-2982.2011.01707.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
84 Yoshihara K, Yajima T, Kubo C, Yoshikai Y. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut. 2006;55:334-341. [PMID: 16162679 DOI: 10.1136/gut.2005.076000] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
85 Manoharan P, Sundaram S, Singh S, Sundaram U. Inducible Nitric Oxide Regulates Brush Border Membrane Na-Glucose Co-transport, but Not Na:H Exchange via p38 MAP Kinase in Intestinal Epithelial Cells. Cells 2018;7:E111. [PMID: 30126234 DOI: 10.3390/cells7080111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
86 Németh ZH, Deitch EA, Szabó C, Mabley JG, Pacher P, Fekete Z, Hauser CJ, Haskó G. Na + /H + exchanger blockade inhibits enterocyte inflammatory response and protects against colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2002;283:G122-32. [DOI: 10.1152/ajpgi.00015.2002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
87 Choi E, Hwang Y, Lee J, Choi J, Choi I, Jin J, Ko JS, Kim S. Lipid A-associated proteins from Porphyromonas gingivalis stimulate release of nitric oxide by inducing expression of inducible nitric oxide synthase. J Periodontal Res 2007;42:350-60. [DOI: 10.1111/j.1600-0765.2006.00956.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
88 Colón AL, Madrigal JL, Menchén LA, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig Dis Sci. 2004;49:1713-1721. [PMID: 15573932 DOI: 10.1023/b:ddas.0000043391.64073.e4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
89 dos Reis Barbosa AL, de Sousa RB, Torres JN, Cunha TM, de Queiroz Cunha F, Soares PM, de Albuquerque Ribeiro R, Vale ML, Souza MH. Colitis generates remote antinociception in rats: the role of the L-arginine/NO/cGMP/PKG/KATP pathway and involvement of cannabinoid and opioid systems. Inflamm Res 2014;63:969-77. [PMID: 25286904 DOI: 10.1007/s00011-014-0773-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Kim S, Ha M, Choi E, Choi J, Choi I. Nitric oxide production and inducible nitric oxide synthase expression induced by Prevotella nigrescens lipopolysaccharide. FEMS Immunology & Medical Microbiology 2005;43:51-8. [DOI: 10.1016/j.femsim.2004.07.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
91 Rashidian A, Keshavarz-bahaghighat H, Abdollahi A, Chamanara M, Faghir-ghanesefat H, Hoseini-ahmadabadi M, Dehpour AR. Agmatine ameliorates acetic acid-induced colitis in rats: involvement of nitrergic system. Immunopharmacology and Immunotoxicology 2019;41:242-9. [DOI: 10.1080/08923973.2019.1578973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Wang D, DuBois RN. Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis 2015;36:1085-93. [PMID: 26354776 DOI: 10.1093/carcin/bgv123] [Cited by in Crossref: 148] [Cited by in F6Publishing: 128] [Article Influence: 24.7] [Reference Citation Analysis]
93 Barrett CW, Ning W, Chen X, Smith JJ, Washington MK, Hill KE, Coburn LA, Peek RM, Chaturvedi R, Wilson KT, Burk RF, Williams CS. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Cancer Res 2013;73:1245-55. [PMID: 23221387 DOI: 10.1158/0008-5472.CAN-12-3150] [Cited by in Crossref: 100] [Cited by in F6Publishing: 56] [Article Influence: 11.1] [Reference Citation Analysis]
94 Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol. 2003;139:209-218. [PMID: 12770926 DOI: 10.1038/sj.bjp.0705241] [Cited by in Crossref: 172] [Cited by in F6Publishing: 151] [Article Influence: 10.1] [Reference Citation Analysis]
95 Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields JZ. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut. 2003;52:720-728. [PMID: 12692059 DOI: 10.1136/gut.52.5.720] [Cited by in Crossref: 164] [Cited by in F6Publishing: 159] [Article Influence: 9.1] [Reference Citation Analysis]
96 Tao Y, Hart J, Lichtenstein L, Joseph LJ, Ciancio MJ, Hu S, Chang EB, Bissonnette M. Inducible heat shock protein 70 prevents multifocal flat dysplastic lesions and invasive tumors in an inflammatory model of colon cancer. Carcinogenesis. 2009;30:175-182. [PMID: 19005184 DOI: 10.1093/carcin/bgn256] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
97 Gushima M, Hirahashi M, Matsumoto T, Fujita K, Fujisawa R, Mizumoto K, Nakabeppu Y, Iida M, Yao T, Tsuneyoshi M. Altered expression of MUTYH and an increase in 8-hydroxydeoxyguanosine are early events in ulcerative colitis-associated carcinogenesis. J Pathol. 2009;219:77-86. [PMID: 19479711 DOI: 10.1002/path.2570] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
98 Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287:G7-17. [PMID: 15194558 DOI: 10.1152/ajpgi.00079.2004] [Cited by in Crossref: 797] [Cited by in F6Publishing: 703] [Article Influence: 46.9] [Reference Citation Analysis]
99 Tanaka S, Miura S, Kimura H, Ohkubo N, Tsuzuki Y, Fukumura D, Serizawa H, Kurose I, Mori M, Ishii H. Amelioration of chronic inflammation by ingestion of elemental diet in a rat model of granulomatous enteritis. Dig Dis Sci 1997;42:408-19. [PMID: 9052527 DOI: 10.1023/a:1018890624384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Mei Q, Xu JM, Xiang L, Hu YM, Hu XP, Xu ZW. Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro. Postgrad Med J 2005;81:667-72. [PMID: 16210467 DOI: 10.1136/pgmj.2004.030817] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
101 Kim SJ, Choi EY, Cho YJ, Lee JY, Choi JI, Choi IS. Surface-associated material from Porphyromonas gingivalis stimulates the release of nitric oxide by inducing expression of inducible nitric oxide synthase. Microbes Infect 2006;8:470-7. [PMID: 16297649 DOI: 10.1016/j.micinf.2005.07.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
102 Dobosz M, Mionskowska L, Dobrowolski S, Dymecki D, Makarewicz W, Hrabowska M, Wajda Z. Is nitric oxide and heparin treatment justified in inflammatory bowel disease? An experimental study. Scandinavian Journal of Clinical and Laboratory Investigation 2011;56:657-63. [DOI: 10.1080/00365519609090602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
103 Roberts PJ, Riley GP, Morgan K, Miller R, Hunter JO, Middleton SJ. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol. 2001;54:293-297. [PMID: 11304846 DOI: 10.1136/jcp.54.4.293] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
104 zandecki M, raeymaekers P, janssens J, tack J, berghe PV. The effect of nitric oxide donors on nitric oxide synthase-expressing myenteric neurones in culture1. Neurogastroenterol Motil 2006;18:307-15. [DOI: 10.1111/j.1365-2982.2005.00755.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
105 Yu H, Sato EF, Nagata K, Nishikawa M, Kashiba M, Arakawa T, Kobayashi K, Tamura T, Inoue M. Oxygen-dependent regulation of the respiration and growth of Escherichia coli by nitric oxide. FEBS Lett 1997;409:161-5. [PMID: 9202138 DOI: 10.1016/s0014-5793(97)00494-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
106 Vermeiren J, Van de Wiele T, Van Nieuwenhuyse G, Boeckx P, Verstraete W, Boon N. Sulfide- and nitrite-dependent nitric oxide production in the intestinal tract. Microb Biotechnol 2012;5:379-87. [PMID: 22129449 DOI: 10.1111/j.1751-7915.2011.00320.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
107 Leonard N, Bishop AE, Polak JM, Talbot IC. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. J Clin Pathol. 1998;51:750-753. [PMID: 10023337 DOI: 10.1136/jcp.51.10.750] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
108 Izzo AA, Sautebin L, Borrelli F, Longo R, Capasso F. The role of nitric oxide in aloe-induced diarrhoea in the rat. Eur J Pharmacol 1999;368:43-8. [PMID: 10096768 DOI: 10.1016/s0014-2999(99)00007-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
109 Dijkstra G, Moshage H, Van Dullemen HM, de Jager-krikken A, Tiebosch ATMG, Kleibeuker JH, Jansen PLM, Van Goor H. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998;186:416-21. [DOI: 10.1002/(sici)1096-9896(199812)186:4<416::aid-path201>3.0.co;2-u] [Cited by in Crossref: 139] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
110 Banan A, Zhang LJ, Farhadi A, Fields JZ, Shaikh M, Forsyth CB, Choudhary S, Keshavarzian A. Critical role of the atypical {lambda} isoform of protein kinase C (PKC-{lambda}) in oxidant-induced disruption of the microtubule cytoskeleton and barrier function of intestinal epithelium. J Pharmacol Exp Ther. 2005;312:458-471. [PMID: 15347733 DOI: 10.1124/jpet.104.074591] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
111 Arthur S, Manoharan P, Sundaram S, Rahman MM, Palaniappan B, Sundaram U. Unique Regulation of Enterocyte Brush Border Membrane Na-Glutamine and Na-Alanine Co-Transport by Peroxynitrite during Chronic Intestinal Inflammation. Int J Mol Sci 2019;20:E1504. [PMID: 30917504 DOI: 10.3390/ijms20061504] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
112 McCafferty DM. Peroxynitrite and inflammatory bowel disease. Gut 2000;46:436-9. [PMID: 10673312 DOI: 10.1136/gut.46.3.436] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
113 Goodman JE, Hofseth LJ, Hussain SP, Harris CC. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 2004;44:3-9. [PMID: 15199542 DOI: 10.1002/em.20024] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
114 Colón AL, Menchén L, Lizasoain I, Leza JC, Menchén P, González-Lara V, Moro MA, Lorenzo P. Inducible nitric oxide synthase activity is expressed not only in inflamed but also in normal colonic mucosa in patients with ulcerative colitis: a potential prognostic marker. Am J Gastroenterol 2000;95:1371-3. [PMID: 10811365 DOI: 10.1111/j.1572-0241.2000.02047.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
115 Kolaja KL, Bell RR, Janssen D, Manning PT, Schlosser MJ, Khan KNM. Evaluation of the long-term pancreatic effects of constitutive nitric oxide synthase inhibition in dogs. Inflammopharmacology 2004;12:33-45. [DOI: 10.1163/156856004773121356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
116 Chamulitrat W. EPR studies of nitric oxide interactions of alkoxyl and peroxyl radicals in in vitro and ex vivo model systems. Antioxid Redox Signal 2001;3:177-87. [PMID: 11396474 DOI: 10.1089/152308601300185151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
117 Bernstein H, Holubec H, Bernstein C, Ignatenko NA, Gerner E, Dvorak K, Besselsen D, Blohm-Mangone KA, Padilla-Torres J, Dvorakova B, Garewal H, Payne CM. Deoxycholate-induced colitis is markedly attenuated in Nos2 knockout mice in association with modulation of gene expression profiles. Dig Dis Sci 2007;52:628-42. [PMID: 17253130 DOI: 10.1007/s10620-006-9608-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
118 Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 2005;11:5787-5794. [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
119 Pompili S, Sferra R, Gaudio E, Viscido A, Frieri G, Vetuschi A, Latella G. Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease? Int J Mol Sci 2019;20:E4061. [PMID: 31434263 DOI: 10.3390/ijms20164061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
120 Kruidenier L, Verspaget HW. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous? Aliment Pharmacol Ther. 2002;16:1997-2015. [PMID: 12452933 DOI: 10.1046/j.1365-2036.2002.01378.x] [Cited by in Crossref: 251] [Cited by in F6Publishing: 228] [Article Influence: 13.9] [Reference Citation Analysis]
121 Maity S, Ukil A, Karmakar S, Datta N, Chaudhuri T, Vedasiromoni JR, Ganguly DK, Das PK. Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. Eur J Pharmacol. 2003;470:103-112. [PMID: 12787838 DOI: 10.1016/s0014-2999(03)01760-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
122 Balasuriya GK, Mohsenipour M, Brassington K, Dobric A, De Luca SN, Mou K, Seow HJ, Lee CYQ, Herath M, Chan SMH, Vlahos R, Hill-Yardin EL. Ebselen prevents cigarette smoke-induced gastrointestinal dysfunction in mice. Clin Sci (Lond) 2020;134:2943-57. [PMID: 33125061 DOI: 10.1042/CS20200886] [Reference Citation Analysis]
123 Zuckerbraun BS, Otterbein LE, Boyle P, Jaffe R, Upperman J, Zamora R, Ford HR. Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005;289:G607-13. [PMID: 15890710 DOI: 10.1152/ajpgi.00055.2005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
124 Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185. [PMID: 24901008 DOI: 10.1155/2014/149185] [Cited by in Crossref: 715] [Cited by in F6Publishing: 679] [Article Influence: 102.1] [Reference Citation Analysis]
125 Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci. 2004;49:1752-1757. [PMID: 15628697 DOI: 10.1007/s10620-004-9564-5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
126 Seril DN, Liao J, Yang GY. Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis. Mol Carcinog 2007;46:341-53. [PMID: 17219424 DOI: 10.1002/mc.20282] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
127 Rezaie A, Khalaj S, Shabihkhani M, Nikfar S, Zamani MJ, Mohammadirad A, Daryani NE, Abdollahi M. Study on the Correlations among Disease Activity Index and Salivary Transforming Growth Factor-beta1 and Nitric Oxide in Ulcerative Colitis Patients. Annals of the New York Academy of Sciences 2007;1095:305-14. [DOI: 10.1196/annals.1397.034] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
128 Gupta SK, Fitzgerald JF, Chong SK, Croffie JM, Garcia JG. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population. Am J Gastroenterol 1998;93:795-8. [PMID: 9625130 DOI: 10.1111/j.1572-0241.1998.227_a.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
129 Rachmilewitz D. Increased colonic nitric oxide level in active IBD. Scandinavian Journal of Gastroenterology 2009;43:638-638. [DOI: 10.1080/00365520701818045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
130 Kwon KH, Murakami A, Tanaka T, Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol. 2005;69:395-406. [PMID: 15652231 DOI: 10.1016/j.bcp.2004.10.015] [Cited by in Crossref: 152] [Cited by in F6Publishing: 136] [Article Influence: 8.9] [Reference Citation Analysis]
131 Rahman SU, Li Y, Huang Y, Zhu L, Feng S, Wu J, Wang X. Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches. Inflammopharmacol 2018;26:319-30. [DOI: 10.1007/s10787-018-0462-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 10.3] [Reference Citation Analysis]
132 Ljung T, Beijer E, Herulf M, Weitzberg E, Lundberg JON, Finkel Y, Hellström PM. Increased Rectal Nitric Oxide in Children With Active Inflammatory Bowel Disease: . Journal of Pediatric Gastroenterology and Nutrition 2002;34:302-6. [DOI: 10.1097/00005176-200203000-00016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
133 Ercin CN, Yesilova Z, Korkmaz A, Ozcan A, Oktenli C, Uygun A. The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis. Dig Dis Sci 2009;54:75-9. [PMID: 18972208 DOI: 10.1007/s10620-008-0498-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
134 Lechner M, Karlseder A, Niederseer D, Lirk P, Neher A, Rieder J, Tilg H. H. pylori Infection Increases Levels of Exhaled Nitrate. Helicobacter 2005;10:385-90. [DOI: 10.1111/j.1523-5378.2005.00345.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
135 Buisson A, Bringer MA, Barnich N, Vazeille E. Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease. Inflamm Bowel Dis 2016;22:2943-55. [PMID: 27824652 DOI: 10.1097/MIB.0000000000000946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Kwon KH, Murakami A, Hayashi R, Ohigashi H. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis. Biochem Biophys Res Commun 2005;337:647-54. [PMID: 16202978 DOI: 10.1016/j.bbrc.2005.09.107] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 5.1] [Reference Citation Analysis]
137 Singh S, Arthur S, Sundaram U. Mechanisms of Regulation of Transporters of Amino Acid Absorption in Inflammatory Bowel Diseases. Compr Physiol 2020;10:673-86. [PMID: 32163200 DOI: 10.1002/cphy.c190016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
138 Singh VP, Patil CS, Jain NK, Singh A, Kulkarni SK. Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats. Prostaglandins Other Lipid Mediat. 2003;71:163-175. [PMID: 14518559 DOI: 10.1016/s1098-8823(03)00038-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
139 Stoyanova II, Gulubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem. 2002;104:185-192. [PMID: 12086339 DOI: 10.1078/0065-1281-00641] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 4.8] [Reference Citation Analysis]
140 Ockenga J, Borchert K, Stüber E, Lochs H, Manns MP, Bischoff SC. Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutr 2005;59:1302-9. [PMID: 16077744 DOI: 10.1038/sj.ejcn.1602243] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
141 Hausel P, Latado H, Courjault-Gautier F, Felley-Bosco E. Src-mediated phosphorylation regulates subcellular distribution and activity of human inducible nitric oxide synthase. Oncogene 2006;25:198-206. [PMID: 16116474 DOI: 10.1038/sj.onc.1209030] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
142 Grisham MB, Kawachi S, Laroux FS, Gray L, Hoffman J, van der Heyde H. Role of nitric oxide in chronic gut inflammation. In: Salvemini D, Billiar TR, Vodovotz Y, editors. Nitric Oxide and Inflammation. Basel: Birkhäuser; 2001. pp. 161-77. [DOI: 10.1007/978-3-0348-8241-5_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Sun J, Shi YH, Le GW, Ma XY. Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J Gastroenterol 2005;11:6330-7. [PMID: 16419162 DOI: 10.3748/wjg.v11.i40.6330] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
144 Soufli I, Toumi R, Rafa H, Touil-Boukoffa C. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016;7:353-60. [PMID: 27602236 DOI: 10.4292/wjgpt.v7.i3.353] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 109] [Article Influence: 27.6] [Reference Citation Analysis]
145 Gibson PR, Anderson RP, Mariadason JM, Wilson AJ. Protective role of the epithelium of the small intestine and colon. Inflamm Bowel Dis 1996;2:279-302. [DOI: 10.1002/ibd.3780020412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
146 Zhang Y, Zhang H, Zhang K, Li Z, Guo T, Wu T, Hou X, Feng N. Co-hybridized composite nanovesicles for enhanced transdermal eugenol and cinnamaldehyde delivery and their potential efficacy in ulcerative colitis. Nanomedicine 2020;28:102212. [PMID: 32334099 DOI: 10.1016/j.nano.2020.102212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
147 Beaumont M, Andriamihaja M, Lan A, Khodorova N, Audebert M, Blouin JM, Grauso M, Lancha L, Benetti PH, Benamouzig R, Tomé D, Bouillaud F, Davila AM, Blachier F. Detrimental effects for colonocytes of an increased exposure to luminal hydrogen sulfide: The adaptive response. Free Radic Biol Med 2016;93:155-64. [PMID: 26849947 DOI: 10.1016/j.freeradbiomed.2016.01.028] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 14.4] [Reference Citation Analysis]
148 Tugay M, Yildiz F, Utkan Z, Utkan T, Sarioğlu Y. Impaired gastric motility in the gastroesophageal reflux rat model: an in vitro study. Journal of Surgical Research 2003;115:272-8. [DOI: 10.1016/s0022-4804(03)00237-3] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
149 Cavicchi M, Whittle BJ. Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP. Gut 1999;45:367-74. [PMID: 10446104 DOI: 10.1136/gut.45.3.367] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
150 Rachmilewitz D. On smoking, rats, and inflammatory bowel disease. Gastroenterology 1999;117:1008-11. [DOI: 10.1016/s0016-5085(99)70360-4] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
151 Stein RB, Lichtenstein GR, Rombeau JL. Nutrition in inflammatory bowel disease: . Current Opinion in Clinical Nutrition and Metabolic Care 1999;2:367-71. [DOI: 10.1097/00075197-199909000-00003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
152 Duggan C, Gannon J, Walker WA. Protective nutrients and functional foods for the gastrointestinal tract. The American Journal of Clinical Nutrition 2002;75:789-808. [DOI: 10.1093/ajcn/75.5.789] [Cited by in Crossref: 141] [Cited by in F6Publishing: 101] [Article Influence: 7.4] [Reference Citation Analysis]
153 Girard P, Pansart Y, Gillardin JM. Inducible nitric oxide synthase involvement in the mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhoea in rats. Nitric Oxide 2005;13:163-9. [PMID: 16039151 DOI: 10.1016/j.niox.2005.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
154 Baier J, Gänsbauer M, Giessler C, Arnold H, Muske M, Schleicher U, Lukassen S, Ekici A, Rauh M, Daniel C, Hartmann A, Schmid B, Tripal P, Dettmer K, Oefner PJ, Atreya R, Wirtz S, Bogdan C, Mattner J. Arginase impedes the resolution of colitis by altering the microbiome and metabolome. J Clin Invest 2020;130:5703-20. [PMID: 32721946 DOI: 10.1172/JCI126923] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
155 Caballol B, Gudiño V, Panes J, Salas A. Ulcerative colitis: shedding light on emerging agents and strategies in preclinical and early clinical development. Expert Opin Investig Drugs 2021;:1-16. [PMID: 34365869 DOI: 10.1080/13543784.2021.1965122] [Reference Citation Analysis]
156 Kodama K, Sumii K, Kawano M, Kido T, Nojima K, Sumii M, Haruma K, Yoshihara M, Chayama K. Helicobacter pylori infection increases serum nitrate and nitrite more prominently than serum pepsinogens. Helicobacter 2002;7:9-13. [PMID: 12017117 DOI: 10.1046/j.1523-5378.2002.00050.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
157 van Bergeijk JD, van Westreenen H, Adhien P, Zijlstra FJ. Diminished nitroprusside-induced relaxation of inflamed colonic smooth muscle in mice. Mediators Inflamm 1998;7:283-7. [PMID: 9792339 DOI: 10.1080/09629359890974] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
158 Theiss AL, Sitaraman SV. The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta. 2011;1813:1137-1143. [PMID: 21296110 DOI: 10.1016/j.bbamcr.2011.01.033] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 10.2] [Reference Citation Analysis]
159 Mangerich A, Dedon PC, Fox JG, Tannenbaum SR, Wogan GN. Chemistry meets biology in colitis-associated carcinogenesis. Free Radic Res. 2013;47:958-986. [PMID: 23926919 DOI: 10.3109/10715762.2013.832239] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
160 Das UN. Can glucose-insulin-potassium regimen suppress inflammatory bowel disease? Med Hypotheses. 2001;57:183-185. [PMID: 11461170 DOI: 10.1054/mehy.2001.1334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
161 Penning TD, Fretland DJ, Stealey MA. Patent Update: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Anti-inflammatory patent highlights from July 1994 to April 1995. Expert Opinion on Therapeutic Patents 2008;5:623-51. [DOI: 10.1517/13543776.5.7.623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
162 Liu BG, Jia XM, Cao YY, Chen SH, Gao PH, Wang Y, Jiang YY, Cao YB. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions. J Ethnopharmacol. 2008;115:1-8. [PMID: 17964746 DOI: 10.1016/j.jep.2007.08.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
163 Colón AL, Menchén LA, Hurtado O, De Cristóbal J, Lizasoain I, Leza JC, Lorenzo P, Moro MA. Implication of TNF-alpha convertase (TACE/ADAM17) in inducible nitric oxide synthase expression and inflammation in an experimental model of colitis. Cytokine. 2001;16:220-226. [PMID: 11884025 DOI: 10.1006/cyto.2001.0969] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
164 Kennedy M, Denenberg AG, Szabó C, Salzman AL. Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 1998;114:510-8. [PMID: 9496941 DOI: 10.1016/s0016-5085(98)70534-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
165 Peuhkuri, Nevala, Vapaatalo, Moilanen, Korpela. Ibuprofen augments gastrointestinal symptoms in lactose maldigesters during a lactose tolerance test: IBUPROFEN AND SYMPTOMS IN LACTOSE MALDIGESTERS. Alimentary Pharmacology & Therapeutics 1999;13:1227-33. [DOI: 10.1046/j.1365-2036.1999.00608.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
166 Fábrega MJ, Rodríguez-Nogales A, Garrido-Mesa J, Algieri F, Badía J, Giménez R, Gálvez J, Baldomà L. Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice. Front Microbiol 2017;8:1274. [PMID: 28744268 DOI: 10.3389/fmicb.2017.01274] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 13.5] [Reference Citation Analysis]
167 Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol. 2015;3:62. [PMID: 26484345 DOI: 10.3389/fcell.2015.00062] [Cited by in Crossref: 98] [Cited by in F6Publishing: 86] [Article Influence: 16.3] [Reference Citation Analysis]
168 Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS. Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut. 1998;43:512-518. [PMID: 9824579 DOI: 10.1136/gut.43.4.512] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
169 Zhang L, Li L, Gao G, Wei G, Zheng Y, Wang C, Gao N, Zhao Y, Deng J, Chen H, Sun J, Li D, Zhang X, Liu M. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress. Int J Cancer 2017;140:2734-47. [PMID: 28316092 DOI: 10.1002/ijc.30698] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
170 Guslandi M. Nitric oxide and inflammatory bowel diseases. Eur J Clin Invest. 1998;28:904-907. [PMID: 9824433 DOI: 10.1046/j.1365-2362.1998.00377.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 74] [Article Influence: 4.1] [Reference Citation Analysis]
171 Oz HS, Zhong J, de Villiers WJ. Pegylated arginine deiminase downregulates colitis in murine models. Mediators Inflamm. 2012;2012:813892. [PMID: 22315509 DOI: 10.1155/2012/813892] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
172 Kolios G, Manousou P, Bourikas L, Notas G, Tsagarakis N, Mouzas I, Kouroumalis E. Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epithelium. Eur J Clin Invest 2006;36:720-9. [PMID: 16968468 DOI: 10.1111/j.1365-2362.2006.01710.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
173 Robinson AM, Rahman AA, Carbone SE, Randall-demllo S, Filippone R, Bornstein JC, Eri R, Nurgali K. Alterations of colonic function in the Winnie mouse model of spontaneous chronic colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017;312:G85-G102. [DOI: 10.1152/ajpgi.00210.2016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
174 Forte P, Dykhuizen RS, Milne E, McKenzie A, Smith CC, Benjamin N. Nitric oxide synthesis in patients with infective gastroenteritis. Gut 1999;45:355-61. [PMID: 10446102 DOI: 10.1136/gut.45.3.355] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
175 Herulf M, Ljung T, Hellström PM, Weitzberg E, Lundberg JO. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand J Gastroenterol. 1998;33:164-169. [PMID: 9517527 DOI: 10.1080/00365529850166897] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis]
176 Murthy S, Flanigan A, Osborne BJ, Murthy NS. Inflammatory bowel diseases: a new wave of therapy. Expert Opinion on Therapeutic Patents 2005;8:785-818. [DOI: 10.1517/13543776.8.7.785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
177 Borunova SF, Tkachev N, Iolchiev B, Artyushina Z, Abramov P, Nikitina M, Silanteva A, Khusnetdinova N, Serezhenkov V. Estimation of Nitrite-Nitric Oxide Derivative-In Horses with Intestinal Colic by ESR Spectroscopy. Vet Sci 2020;7:E191. [PMID: 33260335 DOI: 10.3390/vetsci7040191] [Reference Citation Analysis]
178 Vardareli E, Dundar E, Angin K, Saricam T, Inal M. Effects of intrarectal and intraperitoneal N(G)-nitro-L-arginine methyl ester treatment in 2,4,6-trinitrobenzenesulfonic acid induced colitis in rats. Exp Toxicol Pathol. 2003;55:271-276. [PMID: 14703773 DOI: 10.1078/0940-2993-00324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
179 Lundberg JO. Rectal NO and fecal calprotectin in IBD. Scandinavian Journal of Gastroenterology 2009;44:128-128. [DOI: 10.1080/00365520802647939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Lundberg J. Airborne nitric oxide: Inflammatory marker and aerocrine messenger in man. Acta Physiol Scand 1996;157:4-27. [PMID: 28666068 DOI: 10.1111/apha.1996.157.s633.4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
181 Niveloni S, Weksler-Zangen S, Pedreira S, Dezi R, Granot E, Doldan I, Wengrower D, Vazquez H, Smecuol E, Valero J, Kogan Z, Maurino E, Bai JC, Goldin E. Time course of nitric oxide synthase generation after gluten exposure in the rectal mucosa of gluten-sensitive patients. Scand J Gastroenterol 2000;35:1150-6. [PMID: 11145285 DOI: 10.1080/003655200750056619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
182 Gibson PR, Anderson RP, Mariadason JM, Wilson AJ. Protective Role of the Epithelium of the Small Intestine and Colon: . Inflammatory Bowel Diseases 1996;2:279-302. [DOI: 10.1097/00054725-199612000-00011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
183 van Deventer SJ. Small therapeutic molecules for the treatment of inflammatory bowel disease. Gut 2002;50 Suppl 3:III47-53. [PMID: 11953333 DOI: 10.1136/gut.50.suppl_3.iii47] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
184 Ukil A, Maity S, Das PK. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol. 2006;149:121-131. [PMID: 16880762 DOI: 10.1038/sj.bjp.0706847] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 4.3] [Reference Citation Analysis]
185 Nowicki PT, Reber KM, Giannone PJ, Nankervis CA, Hammond S, Besner GE, Caniano DA. Intestinal O2 Consumption in Necrotizing Enterocolitis: Role of Nitric Oxide. Pediatr Res 2006;59:500-5. [DOI: 10.1203/01.pdr.0000203094.27615.5f] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
186 Hokari A, Zeniya M, Esumi H, Kawabe T, Gershwin ME, Toda G. Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury. J Gastroenterol Hepatol. 2002;17:308-315. [PMID: 11982702 DOI: 10.1046/j.1440-1746.2002.02689.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
187 Bouin M, Delvaux M, Blanc C, Lagier E, Delisle M, Fioramonti J, Buéno L, Frexinos J. Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance: . European Journal of Gastroenterology & Hepatology 2001;13:573-80. [DOI: 10.1097/00042737-200105000-00018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
188 Salas A, Gironella M, Salas A, Soriano A, Sans M, Iovanna J, Pique JM, Panes J. Nitric oxide supplementationameliorates dextran sulfate sodium-induced colitis in mice. Lab Invest. 2002;82:597-607. [PMID: 12004000 DOI: 10.1038/labinvest.3780454] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
189 Deol PK, Kaur IP. Improving the therapeutic efficiency of ginger extract for treatment of colon cancer using a suitably designed multiparticulate system. J Drug Target 2013;21:855-65. [PMID: 23962278 DOI: 10.3109/1061186X.2013.829076] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
190 Chazotte-aubert L, Hainaut P, Ohshima H. Nitric Oxide Nitrates Tyrosine Residues of Tumor-Suppressor p53 Protein in MCF-7 Cells. Biochemical and Biophysical Research Communications 2000;267:609-13. [DOI: 10.1006/bbrc.1999.2003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 2.5] [Reference Citation Analysis]
191 Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med. 2002;33:311-322. [PMID: 12126753 DOI: 10.1016/s0891-5849(02)00853-5] [Cited by in Crossref: 259] [Cited by in F6Publishing: 98] [Article Influence: 14.4] [Reference Citation Analysis]
192 Parasher G, Frenklakh L, Goodman, Siddiqui T, Nandi J, Levine RA. Nitric oxide inhibitors ameliorate indomethacin-induced enteropathy in rats. Dig Dis Sci 2001;46:2536-41. [PMID: 11713966 DOI: 10.1023/a:1012304710187] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
193 Nijakowski K, Surdacka A. Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review. Int J Mol Sci 2020;21:E7477. [PMID: 33050496 DOI: 10.3390/ijms21207477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
194 Yang GY, Taboada S, Liao J. Inflammatory bowel disease: a model of chronic inflammation-induced cancer. Methods Mol Biol. 2009;511:193-233. [PMID: 19347299 DOI: 10.1007/978-1-59745-447-6_9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
195 Protopapas AA, Vradelis S, Karampitsakos T, Steiropoulos P, Chatzimichael A, Paraskakis E. Elevated Levels of Alveolar Nitric Oxide May Indicate Presence of Small Airway Inflammation in Patients with Inflammatory Bowel Disease. Lung 2019;197:663-70. [PMID: 31317255 DOI: 10.1007/s00408-019-00253-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
196 Rachmilewitz D, Eliakim R, Ackerman Z, Karmeli F. Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis. Am J Gastroenterol. 1998;93:409-412. [PMID: 9517649 DOI: 10.1111/j.1572-0241.1998.00409.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.1] [Reference Citation Analysis]
197 Banan A, Zhang LJ, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Key role of PLC-gamma in EGF protection of epithelial barrier against iNOS upregulation and F-actin nitration and disassembly. Am J Physiol Cell Physiol 2003;285:C977-93. [PMID: 12788694 DOI: 10.1152/ajpcell.00121.2003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
198 Ahrén C, Jungersten L, Sandberg T. Plasma nitrate as an index of nitric oxide formation in patients with acute infectious diseases. Scand J Infect Dis 1999;31:405-7. [PMID: 10528882 DOI: 10.1080/00365549950163879] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
199 Perner, Rask-madsen. Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders: REVIEW: NITRIC OXIDE IN IBD. Alimentary Pharmacology & Therapeutics 1999;13:135-44. [DOI: 10.1046/j.1365-2036.1999.00453.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
200 Closs EI, Enseleit F, Koesling D, Pfeilschifter JM, Schwarz PM, Förstermann U. Coexpression of inducible NO synthase and soluble guanylyl cyclase in colonic enterocytes: a pathophysiologic signaling pathway for the initiation of diarrhea by gram-negative bacteria? FASEB J 1998;12:1643-9. [PMID: 9837854 DOI: 10.1096/fasebj.12.15.1643] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
201 Saijo F, Milsom AB, Bryan NS, Bauer SM, Vowinkel T, Ivanovic M, Andry C, Granger DN, Rodriguez J, Feelisch M. On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease. Nitric Oxide. 2010;22:155-167. [PMID: 20005300 DOI: 10.1016/j.niox.2009.11.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
202 Soufli I, Toumi R, Rafa H, Amri M, Labsi M, Khelifi L, Nicoletti F, Touil-Boukoffa C. Crude extract of hydatid laminated layer from Echinococcus granulosus cyst attenuates mucosal intestinal damage and inflammatory responses in Dextran Sulfate Sodium induced colitis in mice. J Inflamm (Lond). 2015;12:19. [PMID: 25844068 DOI: 10.1186/s12950-015-0063-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
203 Yashiro M. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease. Dig Dis Sci. 2015;60:2251-2263. [PMID: 25840920 DOI: 10.1007/s10620-015-3646-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
204 Lundberg S, Holst M, Hellstrom PM. Expression of iNOS mRNA associated with suppression of colonic contraction in rat colitis. Acta Physiol 2006;187:489-94. [DOI: 10.1111/j.1748-1716.2006.01576.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
205 Sharna SS, Balasuriya GK, Hosie S, Nithianantharajah J, Franks AE, Hill-Yardin EL. Altered Caecal Neuroimmune Interactions in the Neuroligin-3R451C Mouse Model of Autism. Front Cell Neurosci 2020;14:85. [PMID: 32327975 DOI: 10.3389/fncel.2020.00085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
206 Cenac N, Garcia-villar R, Ferrier L, Larauche M, Vergnolle N, Bunnett NW, Coelho A, Fioramonti J, Bueno L. Proteinase-Activated Receptor-2-Induced Colonic Inflammation in Mice: Possible Involvement of Afferent Neurons, Nitric Oxide, and Paracellular Permeability. J Immunol 2003;170:4296-300. [DOI: 10.4049/jimmunol.170.8.4296] [Cited by in Crossref: 99] [Cited by in F6Publishing: 98] [Article Influence: 5.5] [Reference Citation Analysis]
207 Straaten E, Koster-kamphuis L, Bovee-oudenhoven I, Meer R, Forget P. Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatrica 1999;88:528-31. [DOI: 10.1111/j.1651-2227.1999.tb00169.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
208 Celiberto LS, Bedani R, Dejani NN, Ivo de Medeiros A, Sampaio Zuanon JA, Spolidorio LC, Tallarico Adorno MA, Amâncio Varesche MB, Carrilho Galvão F, Valentini SR, Font de Valdez G, Rossi EA, Cavallini DCU. Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis. PLoS One 2017;12:e0175935. [PMID: 28437455 DOI: 10.1371/journal.pone.0175935] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
209 El-Medany A, Mahgoub A, Mustafa A, Arafa M, Morsi M. The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats. Eur J Pharmacol. 2005;507:291-299. [PMID: 15659320 DOI: 10.1016/j.ejphar.2004.11.036] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
210 Banan A, Farhadi A, Fields JZ, Zhang LJ, Shaikh M, Keshavarzian A. The delta-isoform of protein kinase C causes inducible nitric-oxide synthase and nitric oxide up-regulation: key mechanism for oxidant-induced carbonylation, nitration, and disassembly of the microtubule cytoskeleton and hyperpermeability of barrier of intestinal epithelia. J Pharmacol Exp Ther. 2003;305:482-494. [PMID: 12606598 DOI: 10.1124/jpet.102.047308] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
211 Kazi HA, Qian Z. Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of NFkB. Saudi J Gastroenterol 2009;15:181-7. [PMID: 19636180 DOI: 10.4103/1319-3767.54750] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
212 Macnaughton WK, Aurora AR, Bhamra J, Sharkey KA, Miller MJS. Expression, activity and cellular localization of inducible nitric oxide synthase in rat ileum and colon post-irradiation. International Journal of Radiation Biology 1998;74:255-64. [DOI: 10.1080/095530098141645] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
213 Krzystek-Korpacka M, Fleszar MG, Bednarz-Misa I, Lewandowski Ł, Szczuka I, Kempiński R, Neubauer K. Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings. Int J Mol Sci 2020;21:E1641. [PMID: 32121248 DOI: 10.3390/ijms21051641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
214 Abdelouhab K, Rafa H, Toumi R, Bouaziz S, Medjeber O, Touil-Boukoffa C. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics. Immunopharmacol Immunotoxicol. 2012;34:590-597. [PMID: 22211319 DOI: 10.3109/08923973.2011.641971] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
215 Salzman AL, Eaves–pyles T, Linn SC, Denenberg AG, Szabó C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998;114:93-102. [DOI: 10.1016/s0016-5085(98)70637-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
216 T. Ljung, M. Herulf, E. Beijer, H.. Rectal Nitric Oxide Assessment in Children with Crohn Disease and Ulcerative Colitis. Indicator of Ileocaecal and Colorectal Affection. Scandinavian Journal of Gastroenterology 2009;36:1073-6. [DOI: 10.1080/003655201750422684] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
217 Taha Y, Raab Y, Larsson A, Carlson M, Lööf L, Gerdin B, Thörn M. Vascular endothelial growth factor (VEGF)--a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci. 2004;49:109-115. [PMID: 14992444 DOI: 10.1023/B:DDAS.0000011611.92440.f2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
218 Bódi N, Szalai Z, Bagyánszki M. Nitrergic Enteric Neurons in Health and Disease-Focus on Animal Models. Int J Mol Sci 2019;20:E2003. [PMID: 31022832 DOI: 10.3390/ijms20082003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
219 Korhonen R, Korpela R, Saxelin M, Mäki M, Kankaanranta H, Moilanen E. Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation. 2001;25:223-232. [PMID: 11580098 DOI: 10.1023/a:1010971703271] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
220 Toiyama Y, Araki T, Tanaka K, Mohri Y, Kusunoki M. Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer. In: Kusunoki M, editor. Colitis-Associated Cancer. Tokyo: Springer Japan; 2016. pp. 85-105. [DOI: 10.1007/978-4-431-55522-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
221 Smyth CM, Akasheh N, Woods S, Kay E, Morgan RK, Thornton MA, O'Grady A, Cummins R, Sheils O, Smyth P, Gleich GJ, Murray FM, Costello RW. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 2013;8:e64216. [PMID: 23717571 DOI: 10.1371/journal.pone.0064216] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
222 Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I, Higuchi H, Akiba Y, Hokari R, Hirokawa M, Serizawa H, Ishii H. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci 1997;42:1047-54. [PMID: 9149061 DOI: 10.1023/a:1018849405922] [Cited by in Crossref: 90] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
223 Macnaughton WK, Lowe SS, Cushing K. Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 1998;275:G1353-60. [DOI: 10.1152/ajpgi.1998.275.6.g1353] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
224 Pandurangan AK, Mohebali N, Esa NM, Looi CY, Ismail S, Saadatdoust Z. Gallic acid suppresses inflammation in dextran sodium sulfate-induced colitis in mice: Possible mechanisms. Int Immunopharmacol. 2015;28:1034-1043. [PMID: 26319951 DOI: 10.1016/j.intimp.2015.08.019] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 11.7] [Reference Citation Analysis]
225 Mañé J, Fernández-bañares F, Ojanguren I, Castellá E, Bertrán X, Bartolí R, Alvarez M, Gassull M. Effect of L-arginine on the course of experimental colitis. Clinical Nutrition 2001;20:415-22. [DOI: 10.1054/clnu.2001.0469] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
226 Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol. 2003;201:28-36. [PMID: 12950014 DOI: 10.1002/path.1409] [Cited by in Crossref: 239] [Cited by in F6Publishing: 226] [Article Influence: 13.3] [Reference Citation Analysis]
227 Janakiram NB, Rao CV. iNOS-selective inhibitors for cancer prevention: promise and progress. Future Med Chem 2012;4:2193-204. [PMID: 23190107 DOI: 10.4155/fmc.12.168] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
228 P. Vento, T. Kiviluoto, H. J. Järvi. Changes in Distribution of Three Isoforms of Nitric Oxide Synthase in Ulcerative Colitis. Scandinavian Journal of Gastroenterology 2009;36:180-9. [DOI: 10.1080/00365520118132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
229 Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205. [DOI: 10.1016/s0016-5085(98)70381-6] [Cited by in Crossref: 1456] [Cited by in F6Publishing: 520] [Article Influence: 63.3] [Reference Citation Analysis]
230 Schreiber J, Efron PA, Park JE, Moldawer LL, Barbul A. Adenoviral gene transfer of an NF-κB super-repressor increases collagen deposition in rodent cutaneous wound healing. Surgery 2005;138:940-6. [DOI: 10.1016/j.surg.2005.05.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
231 Mohamed NI, Suddek GM, El-Kashef DH. Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis. Int Immunopharmacol 2021;99:108005. [PMID: 34330056 DOI: 10.1016/j.intimp.2021.108005] [Reference Citation Analysis]
232 Ferretti M, Gionchetti P, Rizzello F, Venturi A, Stella P, Corti F, Mizrahi J, Miglioli M, Campieri M. Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis. Dig Dis Sci 1997;42:2606-11. [PMID: 9440646 DOI: 10.1023/a:1018897519880] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
233 Kaulmann A, Serchi T, Renaut J, Hoffmann L, Bohn T. Carotenoid exposure of Caco-2 intestinal epithelial cells did not affect selected inflammatory markers but altered their proteomic response. Br J Nutr 2012;108:963-73. [PMID: 22152988 DOI: 10.1017/S0007114511006349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
234 Wang J, Chi DS, Laffan JJ, Li C, Ferguson DA Jr, Litchfield P, Thomas E. Comparison of cytotoxin genotypes of Helicobacter pylori in stomach and saliva. Dig Dis Sci 2002;47:1850-6. [PMID: 12184541 DOI: 10.1023/a:1016417200611] [Reference Citation Analysis]
235 Sharma S, Sinha VR. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa. Journal of Controlled Release 2018;272:97-106. [DOI: 10.1016/j.jconrel.2018.01.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
236 Rachmilewitz D, Okon E, Karmeli F. Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohn's disease. Gut 1997;41:358-65. [PMID: 9378392 DOI: 10.1136/gut.41.3.358] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
237 Németh ZH, Deitch EA, Szabó C, Haskó G. Pyrrolidinedithiocarbamate inhibits NF-kappaB activation and IL-8 production in intestinal epithelial cells. Immunol Lett. 2003;85:41-46. [PMID: 12505195 DOI: 10.1016/s0165-2478(02)00208-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
238 O'donnell D, Moynihan J, Finlay G, Keatings V, O'connor C, Mcloughlin P, Fitzgerald M. Exhaled Nitric Oxide and Bronchoalveolar Lavage Nitrite/Nitrate in Active Pulmonary Sarcoidosis. Am J Respir Crit Care Med 1997;156:1892-6. [DOI: 10.1164/ajrccm.156.6.9705013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
239 Janoff EN, Hayakawa H, Taylor DN, Fasching CE, Kenner JR, Jaimes E, Raij L. Nitric oxide production during Vibrio cholerae infection. American Journal of Physiology-Gastrointestinal and Liver Physiology 1997;273:G1160-7. [DOI: 10.1152/ajpgi.1997.273.5.g1160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
240 Snygg, Casselbrant, Pettersson, Holm, Fändriks, Åneman. Tonometric assessment of jejunal mucosal nitric oxide formation in anaesthetized pigs: Jejunal NO. Acta Physiologica Scandinavica 2000;169:39-45. [DOI: 10.1046/j.1365-201x.2000.00678.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
241 Charmandari E, Meadows N, Patel M, Johnston A, Benjamin N. Plasma Nitrate Concentrations in Children with Infectious and Noninfectious Diarrhea: . Journal of Pediatric Gastroenterology and Nutrition 2001;32:423-7. [DOI: 10.1097/00005176-200104000-00006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
242 Asghar MN, Emani R, Alam C, Helenius TO, Grönroos TJ, Sareila O, Din MU, Holmdahl R, Hänninen A, Toivola DM. In vivo imaging of reactive oxygen and nitrogen species in murine colitis. Inflamm Bowel Dis 2014;20:1435-47. [PMID: 24983980 DOI: 10.1097/MIB.0000000000000118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
243 Kalita B, Ranjan R, Singh A, Yashavarddhan MH, Bajaj S, Gupta ML. A Combination of Podophyllotoxin and Rutin Attenuates Radiation Induced Gastrointestinal Injury by Negatively Regulating NF-κB/p53 Signaling in Lethally Irradiated Mice. PLoS One 2016;11:e0168525. [PMID: 28036347 DOI: 10.1371/journal.pone.0168525] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
244 Adesso S, Russo R, Quaroni A, Autore G, Marzocco S. Astragalus membranaceus Extract Attenuates Inflammation and Oxidative Stress in Intestinal Epithelial Cells via NF-κB Activation and Nrf2 Response. Int J Mol Sci 2018;19:E800. [PMID: 29534459 DOI: 10.3390/ijms19030800] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 12.3] [Reference Citation Analysis]
245 Waldner MJ, Neurath MF. Potential avenues for immunotherapy of colitis-associated neoplasia. Immunotherapy 2012;4:397-405. [PMID: 22512634 DOI: 10.2217/imt.12.15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]